Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selumetinib and radioactive iodine in recurrent/metastatic thyroid cancer
NCT02393690Phase 2Completed
- Sponsor
- Academic and Community Cancer Research United
- Start
- May 2015
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
A Phase 2 trial of selumetinib in thyroid cancer, sponsored by Academic and Community Cancer Research United. Started May 2015; status: completed.
02
Drugs
selumetinib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT02393690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393690.